Focused Investors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $179M | Sell |
461,600
-48,200
| -9% | -$17.9M | 6.03% | 5 |
|
|
2026
Q1 | $149M | Sell |
509,800
-12,900
| -2% | -$4.24M | 4.85% | 10 |
|
|
2025
Q4 | $183M | Sell |
522,700
-13,900
| -3% | -$4.7M | 5.83% | 5 |
|
|
2025
Q3 | $173M | Buy |
536,600
+21,700
| +4% | +$6.75M | 5.31% | 7 |
|
|
2025
Q2 | $200M | Buy |
514,900
+9,700
| +2% | +$3.9M | 6.55% | 2 |
|
|
2025
Q1 | $220M | Sell |
505,200
-12,600
| -2% | -$5.06M | 7.06% | 2 |
|
|
2024
Q4 | $191M | Buy |
517,800
+16,200
| +3% | +$6.78M | 6.03% | 3 |
|
|
2024
Q3 | $261M | Buy |
501,600
+33,500
| +7% | +$17.9M | 7.92% | 1 |
|
|
2024
Q2 | $254M | Sell |
468,100
-13,800
| -3% | -$7.29M | 8.24% | 1 |
|
|
2024
Q1 | $250M | Buy |
481,900
+21,350
| +5% | +$10.6M | 7.83% | 1 |
|
|
2023
Q4 | $217M | Sell |
460,550
-5,700
| -1% | -$2.64M | 7.03% | 1 |
|
|
2023
Q3 | $203M | Sell |
466,250
-3,200
| -0.7% | -$1.45M | 7.22% | 2 |
|
|
2023
Q2 | $209M | Sell |
469,450
-2,250
| -0.5% | -$1.04M | 7% | 3 |
|
|
2023
Q1 | $217M | Sell |
471,700
-23,750
| -5% | -$11.3M | 7.47% | 1 |
|
|
2022
Q4 | $254M | Sell |
495,450
-23,400
| -5% | -$11.9M | 8.19% | 1 |
|
|
2022
Q3 | $236M | Sell |
518,850
-12,950
| -2% | -$6.2M | 8.44% | 1 |
|
|
2022
Q2 | $257M | Sell |
531,800
-800
| -0.2% | -$396K | 8.82% | 1 |
|
|
2022
Q1 | $262M | Sell |
532,600
-14,300
| -3% | -$6.54M | 8.33% | 2 |
|
|
2021
Q4 | $254M | Buy |
546,900
+2,200
| +0.4% | +$926K | 7.75% | 2 |
|
|
2021
Q3 | $203M | Sell |
544,700
-19,600
| -3% | -$7.45M | 6.77% | 5 |
|
|
2021
Q2 | $215M | Sell |
564,300
-12,400
| -2% | -$4.74M | 6.86% | 4 |
|
|
2021
Q1 | $207M | Sell |
576,700
-29,700
| -5% | -$9.55M | 7.16% | 3 |
|
|
2020
Q4 | $195M | Sell |
606,400
-100
| -0% | -$30.7K | 7.05% | 4 |
|
|
2020
Q3 | $163M | Sell |
606,500
-15,600
| -3% | -$4.2M | 6.66% | 5 |
|
|
2020
Q2 | $164M | Sell |
622,100
-4,100
| -0.7% | -$1.09M | 7.34% | 4 |
|
|
2020
Q1 | $142M | Buy |
626,200
+9,900
| +2% | +$2.7M | 7.1% | 4 |
|
|
2019
Q4 | $186M | Sell |
616,300
-20,400
| -3% | -$5.61M | 7.38% | 1 |
|
|
2019
Q3 | $153M | Sell |
636,700
-2,700
| -0.4% | -$740K | 6.7% | 3 |
|
|
2019
Q2 | $180M | Sell |
639,400
-13,200
| -2% | -$3.61M | 7.91% | 1 |
|
|
2019
Q1 | $187M | Sell |
652,600
-21,100
| -3% | -$6.1M | 8.18% | 1 |
|
|
2018
Q4 | $177M | Sell |
673,700
-28,500
| -4% | -$7.84M | 8.12% | 1 |
|
|
2018
Q3 | $192M | Sell |
702,200
-2,900
| -0.4% | -$753K | 7.57% | 1 |
|
|
2018
Q2 | $168M | Buy |
705,100
+2,800
| +0.4% | +$648K | 7.2% | 1 |
|
|
2018
Q1 | $154M | Sell |
702,300
-20,200
| -3% | -$4.75M | 6.75% | 1 |
|
|
2017
Q4 | $163M | Sell |
722,500
-17,900
| -2% | -$3.81M | 6.61% | 1 |
|
|
2017
Q3 | $141M | Sell |
740,400
-22,000
| -3% | -$4.19M | 5.96% | 2 |
|
|
2017
Q2 | $143M | Sell |
762,400
-182,400
| -19% | -$32.8M | 6.09% | 2 |
|
|
2017
Q1 | $156M | Buy |
944,800
+106,600
| +13% | +$17M | 5.64% | 5 |
|
|
2016
Q4 | $121M | Sell |
838,200
-16,900
| -2% | -$2.26M | 4.58% | 12 |
|
|
2016
Q3 | $107M | Sell |
855,100
-8,500
| -1% | -$1.1M | 4.25% | 13 |
|
|
2016
Q2 | $113M | Buy |
863,600
+206,700
| +31% | +$28.3M | 4.47% | 10 |
|
|
2016
Q1 | $91.3M | Sell |
656,900
-19,700
| -3% | -$2.63M | 3.51% | 13 |
|
|
2015
Q4 | $94.3M | Sell |
676,600
-52,700
| -7% | -$7.26M | 3.64% | 15 |
|
|
2015
Q3 | $102M | Sell |
729,300
-14,100
| -2% | -$2.12M | 3.74% | 12 |
|
|
2015
Q2 | $122M | Sell |
743,400
-301,500
| -29% | -$48.2M | 4.23% | 10 |
|
|
2015
Q1 | $161M | Buy |
1,044,900
+32,000
| +3% | +$4.56M | 5.59% | 7 |
|
|
2014
Q4 | $127M | Sell |
1,012,900
-64,700
| -6% | -$7.99M | 4.61% | 10 |
|
|
2014
Q3 | $129M | Sell |
1,077,600
-7,100
| -0.7% | -$814K | 4.74% | 10 |
|
|
2014
Q2 | $117M | Sell |
1,084,700
-6,400
| -0.6% | -$659K | 4.38% | 11 |
|
|
2014
Q1 | $109M | Sell |
1,091,100
-35,000
| -3% | -$3.17M | 4.3% | 12 |
|
|
2013
Q4 | $104M | Sell |
1,126,100
-800
| -0.1% | -$71.1K | 4.08% | 11 |
|
|
2013
Q3 | $94.2M | Buy |
1,126,900
+46,200
| +4% | +$3.96M | 4.05% | 12 |
|
|
2013
Q2 | $88.4M | Buy |
+1,080,700
| New | +$80.9M | 3.84% | 13 |
|
Other funds holding ELV
N
Focused Investors's ELV Position: Q2 2026 in Review
Focused Investors reduced its Elevance Health (ELV) stake by 9.5% in Q2 2026, selling an estimated $17.9M and leaving 461,600 shares worth $179M. The position accounts for 6.03% of the portfolio, ranked #5.
Focused Investors first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $262M in Q1 2022. 1,089 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Focused Investors held 461,600 shares of Elevance Health worth $179M as of Q2 2026.
- Focused Investors sold 48,200 Elevance Health shares in Q2 2026, an estimated $17.9M.
- Elevance Health made up 6.03% of Focused Investors's portfolio in Q2 2026, its #5 holding.
- Focused Investors first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Focused Investors's Elevance Health position peaked at $262M in Q1 2022.
- 1,089 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Focused Investors's 13F filing for Q2 2026, filed 28 Jul 2026.